Prevention of cleft lip and palate. Reducing risk of recurrence - A 25-year clinical experience;Prävention von Lippen-Kiefer-Gaumen-Spalten. 25 Jahre klinische Erfahrung in der Senkung des Wiederholungsrisikos

Mund - Kiefer - und Gesichtschirurgie

Volumn 10, Issue 5, 2006, Pages 301-305

  Schubert, Johannes ^a   Krost, Birgit ^a  

^a MARTIN LUTHER UNIVERSITY HALLE WITTENBERG   (Germany)

Author keywords

Cleft lip and palate; Prevention; Prophylaxis; Vitamin B complex; Vitamins

Indexed keywords

ACTOVEGIN; DRUG DERIVATIVE; HEME; VITAMIN B COMPLEX;

ADOLESCENT; ADULT; ARTICLE; CLEFT LIP; CLEFT PALATE; DOSE RESPONSE; DRUG COMBINATION; FEMALE; GENETIC PREDISPOSITION; GENETICS; GESTATIONAL AGE; HUMAN; NEWBORN; PREGNANCY; PREGNANCY OUTCOME; PRENATAL CARE; PROSPECTIVE STUDY; RECURRENT DISEASE; RISK;

ADOLESCENT; ADULT; CLEFT LIP; CLEFT PALATE; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG THERAPY, COMBINATION; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GESTATIONAL AGE; HEME; HUMANS; INFANT, NEWBORN; PREGNANCY; PREGNANCY OUTCOME; PRENATAL CARE; PROSPECTIVE STUDIES; RECURRENCE; RISK; VITAMIN B COMPLEX;

EID: 33748894329     PISSN: 14329417     EISSN: 14343940     Source Type: Journal    
DOI: 10.1007/s10006-006-0020-x     Document Type: Article

References (20)

1. Bianchi F, Calzolari E, Ciulli L et al. (2000) Environment and genetics in the etiology of cleft lip and cleft palate with reference to the role of folic acid. Epidemiol Prev 24:21-27
2. Czeizel AE (1995) Nutritional supplementation and prevention of congenital abnormalities. Curr Opin Obstet Gynecol 7:88-94
3. DePaola DP, Jordan RL (1982) Nutritional aspects of abnormal development. In: Melnick M (ed) Clinical dysmorphology of oral-facial structures. Wright, London, pp 59-71
4. Gabka J (1964) Hasenscharten und Wolfsrachen. De Gruyter, Berlin
5. Gabka J (1967) Actihaemyl in der Kiefer-Gesichtschirurgie unter Berücksichtigung tierexperimenteller Ergebnisse. Med Monatsschr 21:175
6. Kreybig T (1982) Verhütung angeborener Behinderungen: tierexperimentelle und klinische Studien; genetische, toxikologische, biochemische und tiefenpsychologische Aspekte. Abendroth, Hamburg
7. Kreybig T von, Ostermann R, Pfeifer G (1977) Verringerung und Veränderung der Teratogenität von Hydroxamsäuren durch Thiamin (Vitamin B 1) bei der Maus. Mund Kiefer Gesichtschir 1:41-50
8. Kubota Y, Shimotake T, Iwai N (2000) Congenital anomalies in mice induced by etretinate. Eur J Pediatr Surg 10:248-251
9. Lorente CA, Miller SA (1978) The effect of hypervitaminosis A on rat palatal development. Teratology 18:277-284
10. Marks J (1989) The safety of the vitamins: An overview. Int J Vitamin Nutr Res (Suppl) 30:12-20
11. Martius G (1996) Regelwidrige Schwangerschaftsanlage und Nidationsstörung. In: Martius G, Breckwoldt M, Pfleiderer A (Hrsg) Lehrbuch der Gynäkologie und Geburtshilfe, 2. Aufl. Thieme, Stuttgart, S 175
12. Nycomed Pharma (2006) Stellungnahme zur BSE-Sicherheit von Actovegin® in seinen verschiedenen Darreichungsformen. Nycomed Unterschleißheim, 16.02.2006
13. Peer LA, Gordon HW, Bernhard WG (1964) Effect of vitamins on human teratology. Plast Reconstr Surg 34:358-361
14. Schubert J (1980) Untersuchungen zur medikamentösen Beeinflussung experimenteller Gaumenspalten. Med. Dissertation, Martin-Luther-Universität Halle-Wittenberg
15. Schubert J, Schmidt R, Raupach HW (1990) New findings explaining the mode of action in prevention of facial clefting and first clinical experience. J Craniomaxillofac Surg 18:343-347
16. Tariverdian G, Paul M (1999) Genetische Diagnostik in Geburtshilfe und Gynäkologie. Springer, Berlin Heidelberg New York
17. Tolarova M (1987) Orofacial clefts in Czechoslovakia. Incidence, genetics, and prevention of cleft lip and palate over a 19-year period. Scand J Plast Reconstr Surg Hand Surg 21:19-25
18. Tolarova M (2005) Breakthrough in prevention of clefts. 4th Annual Congress of Indian Society of Cleft Lip, Palate and Craniofacial Anomalies, 12-16 January 2005, Hyderabad
19. Tolarova M, Harris J (1995) Reduced recurrence of orofacial clefts after periconceptional supplementation with high-dose folic acid and multivitamins. Teratology 51:71-78
20. Waitzman NJ, Romano PS, Scheffler RM (1994) Estimates of the economic costs of birth defects. Inquiry 31:188-205